While OpenAI charges $60 per million tokens for its flagship reasoning model, a Chinese startup just open-sourced an alternative that matches its performance—at 95% less cost. Meet DeepSeek-R1, the RL-trained model that’s not just competing with Silicon Valley’s AI giants, but in some cases running on consumer laptops in some configurations rather than in data…
How the startup ALAFIA Supercomputers is deploying on-prem AI for medical research and clinical care
Imagine a hospital spending millions on advanced imaging equipment yet relying on decades-old computers to run the software. That paradox propelled robotics and computer vision veteran Camilo Buscaron—a former systems engineer at NVIDIA and Chief Technologist for AWS Robotics—into action. In 2023, he set out to commercialize an open-source computer vision library known as Kornia,…
Sensor data, reimagined: When 90% less data can fuel 100x gains in efficiency in AI projects
For decades, the Nyquist-Shannon theorem—a foundational principle of signal processing—dictated that fully sampling a signal at or above twice its highest frequency was essential for capturing critical information. Now, a Pennsylvania startup called Lightscline suggests we may be entering a “post-Nyquist era.” According to a recent Nature Scientific Reports paper, the company’s neural-network-based software, inspired…
An overview of the late 2024 supercomputing landscape in 6 charts
Over the past couple of years, the world’s most powerful supercomputers have experienced a sizable leap in performance. The combined processing power of the computers on the TOP500 list surged from 5.24 exaflops in June 2023 to 11.72 exaflops in November 2024, representing a 123.7% increase. Meanwhile, the anticipated Colossus supercomputer from Elon Musk’s xAI—if…
Google Cloud exec sees 2025 as a tipping point for GenAI ROI in life sciences
The irony isn’t lost on Google’s leadership: even the architects of artificial intelligence find themselves navigating its transformative effects. “You know, things are never quiet,” remarked Shweta Maniar, global director of healthcare and life sciences at Google Cloud in a recent interview, recalling how Silicon Valley giants vowed to disrupt healthcare among other industries. “I…
Top 15 R&D spenders of 2024
Each year, the top 2,500 or so international R&D spenders collectively invest more than $1 trillion in R&D. The roster of R&D heavyweights is shaping up to look broadly similar to prior years, but NVIDIA is poised to crack into the top 15 given its recent AI-driven growth. If anything, NVIDIA’s ascent into the ranks…
Deloitte: Life sciences leaders signal renewed confidence for 2025
Life sciences executives are entering 2025 with data-driven optimism, according to Deloitte’s newly released “2025 Life Sciences Outlook.” Survey findings from 150 global C-suite executives show that 75% remain upbeat about the year ahead, with 68% anticipating revenue increases and 57% expecting margin expansions. Two key factors emerge from executive interviews: enhanced clarity following the…
25 techbio leaders that shaped the AI-biology convergence in 2024
While the term “biotechnology” was coined in 1919, “techbio” dates back roughly a century after that. Around 2019, the VC firm Artis Ventures set up a venture capital fund named Artis techbio with the aim of uniting software, computational biology, and drug development into a cohesive framework. The ambition behind this idea has sometimes surpassed…
Why David Sacks’ appointment could grease the wheels of medical AI innovation
For Avandra CEO and founder Ryan Tarzy, the potential of AI in healthcare is personal. He lost his father to pancreatic cancer, a disease often caught too late in the United States. At the recent Radiological Society of North America (RSNA) conference, he encountered a telling example of what emerging medical tech can achieve. “At…
3 ‘radical’ premises to reshape pharma R&D with AI—starting with holding off on AI
A good number of organizations rushing to deploy AI in pharmaceutical and genomics research have their priorities backward. They need not only a solid data infrastructure but also true data savviness before forging ahead with deep learning or large language models, argues Stavros Papadopoulos, CEO and founder of TileDB, the developer of data platform for…
How generative AI gave climate modeling a 25x speed boost
A team of researchers at the Allen Institute for AI and UC San Diego have introduced a climate modeling approach boasting 25× speed-ups and associated energy savings over the emulated physics-based model FV3GFS. Specifically, the method takes about 2 hours and 56 minutes to run a 10-year simulation The physics-based FV3GFS model takes about 78 hours…
How the Living Heart Project could transform FDA’s approach to cardiac device testing
Imagine a future where needing a new heart means you become your own donor. “It’s going to be your cells, your design—an exact replica of your heart, only made healthy,” said Steven Levine, Ph.D., senior director of virtual human modeling at Dassault Systèmes, in a recent interview. For Levine, the goal of transforming cardiac care…
The 25 most innovative companies of 2024
Yes, questions remain about whether AI chipmaker NVIDIA can maintain its momentum in 2025. NVIDIA’s upcoming Blackwell AI chips have encountered thermal problems when integrated into server racks designed to house up to 72 units. Despite these recent technical hurdles, the company remains an innovation juggernaut. 1. Why NVIDIA is the R&D leader of 2024…
The great R&D reshuffle of 2024: AI drove significant restructuring across sectors
From enterprise software to drug discovery, artificial intelligence is triggering seismic shifts in corporate R&D strategies. SAP is investing €2 billion annually in AI while planning to cut up to 10,000 jobs. OpenAI is pivoting from its nonprofit roots toward a for-profit model valued at $80 billion. Hardware giants like Intel and AMD are slashing…
R&D Market Pulse: Chip wars heat up with TSMC curbing AI chip exports to China as DuPont rides semiconductor surge
The R&D World Index climbed modestly this week thanks to Intel’s substantial gains and strategic expansions in Asia. At the same time, automotive heavyweight Honda faced significant setbacks, highlighting a week of contrasting fortunes in the R&D landscape. The R&D World Index (RDWI) for the week ending November 8, 2024, closed at 3,918.29 for the…
From NVIDIA to SAP: How 25 global AI patent leaders fared in 2024
NVIDIA’s dominance in the AI hardware landscape is undeniable. The company has a solid IP strategy, too, with a portfolio of 273 granted AI patents across seven internationally jurisdictions as of late October 2024. NVIDIA’s stock has soared 187.6% so far this year, driving its market capitalization to $3.43 trillion. In addition, data center segment,…
R&D Market Pulse: Volvo/Daimler embrace digital alliance, VW restructures, Toyota bets on AI
The R&D World Index (RDWI) for the week ending November 1, 2024, closed at 3,855.65 for the 25 companies in the RDWI. The Index was down -2.70% (or -107.16 basis points). Eight RDWI members gained value last week from 0.16% (Alibaba) to 8.36% (AbbVie). Seventeen RDWI members lost value the previous from -0.43% (Cisco) to…
Wiley backs Potato’s vision to win over skeptical scientists with trustable AI research assistant
A 2016 survey by Nature found that over 70% of researchers have tried and failed to reproduce another scientist’s experiments, and more than half have failed to reproduce their own. One significant challenge contributing to this crisis is the difficulty scientists face in understanding experimental parameters across studies. “The basic problem was massive amounts of…
UK research grant backs Alphawave Semi’s AI network efficiency project
Alphawave Semi has been awarded a research grant from the UK’s Advanced Research + Invention Agency (ARIA), to remove networking bottlenecks that are limiting AI’s growth. Data from Meta indicates that AI processors can be idle roughly two-fifths of the time waiting for data from the network, wasting costly resources. ARIA is driving a shift toward…
Is your R&D in the ‘Valley of Death’?
Every year, thousands of groundbreaking ideas emerge from research labs and universities, brimming with the potential to reshape industries. Yet, a significant number of these innovations never see the light of day. They fall into the abyss ominously termed the “Valley of Death,” which, as a paper in Science Direct puts it, “is an unfavorable…
AI takes center stage in Honeywell-Chevron collaboration
At its Honeywell Users Group event in Dallas, Honeywell and Chevron revealed a strategic alliance that would use AI to streamline operator decision-making in refining processes, aiming to enhance both efficiency and safety. “The focus of the partnership is to use AI to build real, impactful solutions that will set new standards for operational efficiency,”…
Copyleaks CEO: OpenAI’s o1 emergence could blur the lines between human researcher and AI assistant
The web is facing a deluge of AI-generated content, with an explosive 8,362% surge from November 2022 to March 2024, according to a study by Copyleaks. From Q1 2023 to Q1 2024, the volume of AI-detected content jumped 2,848% based on an analysis of more than a million web pages per period using data from…
This week in AI research: OpenAI’s valuation hits $150B as it unveils o1 model family
After nearly a year of rumors surrounding OpenAI’s “Q*” (later “Strawberry“) project and its potential for advanced reasoning, the company has finally unveiled its new “o1” AI models that mirror humans’ ability to think before speaking. These models allocate more processing power to reasoning before generating output, significantly improving accuracy on complex tasks across science,…
Decoding Lubrizol’s AI-driven beauty R&D
At Lubrizol, the quest for better skincare has taken a decidedly high-tech turn, culminating in the recent opening of a new Beauty Research Institute in Shanghai. This facility will serve as a global hub for in-vivo beauty testing. It will also aid the company in developing next-generation ingredients designed to cater to the specific needs…
Scientists explore intelligent biocomputing for neurological disease treatment
What if the combination of stem cell research, bioengineering and biocomputing could help patients with neurological damage? Researchers at the University of California, Irvine (UCI) and the University of Southern California (USC) are embarking on a research initiative to explore that very possibility. With a $2 million grant from the National Science Foundation’s Emerging Frontiers…